Biotech Investing argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients
Biotech Investing argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025
Biotech Investing argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025
SAGA Metals Mobilizes Final Team for Major Drill Program at Radar Project in Labrador, Targeting Maiden Mineral Resource Estimate & Provides Corporate Update
